Back to Browse Journals » International Journal of Nephrology and Renovascular Disease » Volume 7

Obesity, hypertension, and chronic kidney disease

Authors Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE

Received 25 October 2013

Accepted for publication 4 December 2013

Published 18 February 2014 Volume 2014:7 Pages 75—88


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Michael E Hall,1,2 Jussara M do Carmo,2 Alexandre A da Silva,2 Luis A Juncos,1,2 Zhen Wang,2 John E Hall2

1Department of Medicine, 2Department of Physiology and Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson, MS, USA

Abstract: Obesity is a major risk factor for essential hypertension, diabetes, and other comorbid conditions that contribute to development of chronic kidney disease. Obesity raises blood pressure by increasing renal tubular sodium reabsorption, impairing pressure natriuresis, and causing volume expansion via activation of the sympathetic nervous system and renin-angiotensin-aldosterone system and by physical compression of the kidneys, especially when there is increased visceral adiposity. Other factors such as inflammation, oxidative stress, and lipotoxicity may also contribute to obesity-mediated hypertension and renal dysfunction. Initially, obesity causes renal vasodilation and glomerular hyperfiltration, which act as compensatory mechanisms to maintain sodium balance despite increased tubular reabsorption. However, these compensations, along with increased arterial pressure and metabolic abnormalities, may ultimately lead to glomerular injury and initiate a slowly developing vicious cycle that exacerbates hypertension and worsens renal injury. Body weight reduction, via caloric restriction and increased physical activity, is an important first step for management of obesity, hypertension, and chronic kidney disease. However, this strategy may not be effective in producing long-term weight loss or in preventing cardiorenal and metabolic consequences in many obese patients. The majority of obese patients require medical therapy for obesity-associated hypertension, metabolic disorders, and renal disease, and morbidly obese patients may require surgical interventions to produce sustained weight loss.

Keywords: visceral adiposity, type II diabetes, sodium reabsorption, glomerular filtration rate, sympathetic nervous system, renin-angiotensin-aldosterone system

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 


Readers of this article also read:

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

Frugtniet B, Jiang WG, Martin TA

Breast Cancer: Targets and Therapy 2015, 7:99-109

Published Date: 24 April 2015

Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine

Chen Y, Traore YL, Li A, Fowke KR, Ho EA

Drug Design, Development and Therapy 2014, 8:1801-1815

Published Date: 9 October 2014

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Gu N, Park MK, Kim TE, Bahng MY, Lim KS, Cho SH, Yoon SH, Cho JY, Jang IJ, Yu KS

Drug Design, Development and Therapy 2014, 8:1709-1721

Published Date: 6 October 2014

Incorporating the principles of the patient- centered medical home into a student-run free clinic

Riddle MC, Lin J, Steinman JB, Salvi JD, Reynolds MM, Kastor AS, Harris C, Boutin-Foster C

Advances in Medical Education and Practice 2014, 5:289-297

Published Date: 11 September 2014

N-n-butyl haloperidol iodide inhibits H2O2- induced Na+/Ca2+-exchanger activation via the Na+/H+ exchanger in rat ventricular myocytes

Huang YP, Gao FF, Wang B, Zheng FC, Zhang YM, Chen YC, Huang ZQ, Zheng YS, Zhong SP, Shi GG

Drug Design, Development and Therapy 2014, 8:1257-1267

Published Date: 9 September 2014

Fertility preservation during cancer treatment: clinical guidelines

Rodriguez-Wallberg KA, Oktay K

Cancer Management and Research 2014, 6:105-117

Published Date: 4 March 2014

Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world

Aisanov Z, Bai CX, Bauerle O, Colodenco FD, Feldman C, Hashimoto S, Jardim J, Lai CKW, Laniado-Laborin R, Nadeau G, Sayiner A, Shim JJ, Tsai YH, Walters RD, Waterer G

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:271-282

Published Date: 5 April 2012